Late Breaking Abstract - Role of Muscarinic M3 receptors in bronchial remodelling of severe asthma

F. Ricciardolo (Orbassano (To), Italy)

Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Session: Late-breaking findings in asthma and COPD
Session type: Thematic Poster
Number: 1360
Disease area: Airway diseases

Congress or journal article abstractE-poster

Abstract

Late Breaking Abstract - Role of Muscarinic M3 receptors in bronchial remodelling of severe asthma

Rationale. Cholinergic parasympathetic system via the release of acetylcholine (ACh) is a major regulator of airway function but its role in asthma remodelling is unknown. Aim of this study was to evaluate the expression of cholinergic M3 muscarinic receptors (M3R) in relation to vascular, matrix and neural remodelling markers in mild and severe asthma.

Methods. M3R, angiogenin, NGF and procollagen III were analysed by immunohistochemistry in cryostat sections of healthy controls (n=8), mild (n=15) and severe (n=15) asthmatics. Co-localisation of CD31+ (endothelial) and M3R+ cells was evaluated by confocal immunofluorescence. Human bronchial primary fibroblast (HBPF) cultures of controls and asthmatics stimulated with acetylcholine were immunostained for M3R.

Results. In bronchial lamina propria the number of M3R+, angiogenin+, NGF+ cells were higher in severe compared to mild asthmatics and controls (M3R: p<0,01; angiogenin: p<0.05 and p<0.001; NGF: p<0.05 and p<0.001, respectively). Procollagen III was more expressed in severe asthmatics compared to controls (p<0,05). M3R+ cells were related negatively to FEV1 and positively to angiogenin+ and NGF+ cells (p<0.05) in asthmatics. Confocal analysis demonstrated that CD31+ cells co-localised with M3R. In HBPF of healthy controls and asthmatics acetylcholine increased M3R expression.

Conclusions. The results of the study shed light on the role of M3 receptors in the different aspects of asthma remodelling.



Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Ricciardolo (Orbassano (To), Italy). Late Breaking Abstract - Role of Muscarinic M3 receptors in bronchial remodelling of severe asthma. 1360

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Effect of timapiprant, a DP2 antagonist, on airway inflammation in severe eosinophilic asthma
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma
Year: 2019




Cholinergic muscarinic receptors and airway remodelling in severe asthma
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018

Role of muscarinic receptors in airway inflammation and remodelling
Source: International Congress 2015 – Respiratory research in the Netherlands
Year: 2015


The muscarinic M3 receptor regulates allergen-induced airway remodeling in mice
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


Late Breaking Abstract - Airway sensory innervation is increased in chronic cough
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018

Late Breaking Abstract - Calcium-sensing receptor activators increased in the sputum of idiopathic pulmonary fibrosis patients
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019


Late Breaking Abstract - Role of ß-catenin and Notch signalling in increased airway mucous cell differentiation in asthma
Source: International Congress 2019 – Molecular and experimental paediatric lung disease
Year: 2019



Late Breaking Abstract - Airway hyperresponsiveness in bronchiectasis
Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Year: 2019



Expression of CysLT2 receptors in asthmatic lung, and the roles in bronchoconstriction
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014

Late Breaking Abstract - Sex differences in ß2 adrenoceptor-mediated responses in mouse airways
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

Late Breaking Abstract - Transient Receptor Potential Vanilloid subtype 4 in patients with lung cancer
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020




Muscarinic M3 receptors on structural cells regulate neutrophilic inflammation in mice
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014

Role of the acetylcholine in the virus-induced bronchoconstriction
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016

Late Breaking Abstract - IL-36 receptor agonists contribute to a pro-inflammatory milieu in smokers with and without COPD
Source: International Congress 2017 – New immune markers for asthma and COPD
Year: 2017



Late Breaking Abstract - Aerobic exercise reduces asthma phenotype by inhibiting purinergic signaling and lymphatic organs hyperactivation
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017

Late Breaking Abstract - Bronchial Thermoplasty restores constitutive high PRMT1 expression in asthmatic airways
Source: International Congress 2017 – Notable abstracts in asthma
Year: 2017



Late Breaking Abstract - Activation of a murine skeletal muscle M3 muscarinic Designer Receptor Exclusively Activated by Designer Drug (DREADD) has cardiopulmonary consequences
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019


LATE-BREAKING ABSTRACT: A novel role for CCR3 in promoting airways hyperreactivity; Role for CCR3-muscarinic M3 receptor heterodimers
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015

Late Breaking Abstract - Gender and asthma: Gender-dependent effects of obesity on allergic pulmonary inflammation
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018




Late Breaking Abstract - An assessment of potential predictive biomarkers for the treatment of severe eosinophilic asthma with CRTH2 antagonists
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019